ESMO Gynaecological Cancers Congress 2023 Exhibition is the leading platform to showcase the latest research in the field.
This is an outstanding occasion to promote the value of your products and services both in an onsite and online setting.
For information about the exhibition for ESMO Gynaecological Cancers Congress 2023, please download our Exhibition Manual below:
Download the ESMO Gynaecological Cancers Congress 2023 Exhibitor Manual
Contacts
Onsite Exhibition Support
CCIB
E-mail: stands@ccib.es
Online Exhibition Support
ESMO Gynaecological Cancers Congress 2023 secretariat
ESMO Head Office
E-mail: gynae@esmo.org
Official Italian agency for AIFA procedure
AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu